PRICE T ROWE ASSOCIATES INC /MD/
S-8, 1995-04-21
Previous: PRICE T ROWE ASSOCIATES INC /MD/, 8-A12G/A, 1995-04-21
Next: PUBLICKER INDUSTRIES INC, PRER14A, 1995-04-21




As filed with the Securities and Exchange Commission on April 21, 1995
                                            Registration No. 33-
______________________________________________________________________________

               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549
                                
                                
                            FORM S-8
                     REGISTRATION STATEMENT
                              under
                   THE SECURITIES ACT OF 1933
                                
                                
                 T. ROWE PRICE ASSOCIATES, INC.
     (Exact name of registrant as specified in its charter)

                      100 East Pratt Street
                     Baltimore, Maryland  21202
Maryland            (Address of principal                52-0556948
(State or other      executive offices)                  (I.R.S.
jurisdiction of                                          Employer
incorporation or                                         Identification
 organization)                                           No.)
                  T. ROWE PRICE ASSOCIATES INC.
                 1995 DIRECTOR STOCK OPTION PLAN
                    (Full title of the plan)

    GEORGE A. ROCHE                              Copy to:
    T. Rowe Price Associates, Inc.               HENRY D. KAHN
    100 East Pratt Street                        Piper & Marbury
    Baltimore, Maryland  21202                   36 South Charles Street
    (410) 547-2099                               Baltimore, Maryland  21201
                                                 (410) 576-1686
                                
              (Name, address and telephone number,
           including area code, of agent for service)
                                
                                
                 CALCULATION OF REGISTRATION FEE



Title of         Amount       Proposed maxi-     Proposed maxi-   Amount of
securities to    to be        mum offering       mum aggregate    registration
be registered    registered   price per share    offering price   fee
Common Stock
(par value        70,000          $37.00*         $2,590,000      $893.10
$.20 per share)



*Computed in accordance with Rule 457(c) based on the closing price of the
 registrant's common stock on April 18, 1995.
               

                                 PART II

             INFORMATION NOT REQUIRED IN PROSPECTUS


ITEM 3.   INCORPORATION OF DOCUMENTS BY REFERENCE.

      The  following documents have been filed by T.  Rowe  Price
Associates, Inc. (the "Company") with the Securities and Exchange
Commission and are incorporated herein by reference:  (a)  Annual
Report on Form 10-K for the year ended December 31, 1994; and (b)
the  description of the Company's capital stock contained in  its
Registration Statement on Form 8-A, as amended on April 21,  1995
(file number 0-14282).

      All  documents  filed by the Company pursuant  to  Sections
13(a),  13(c), 14 or 15(d) of the Exchange Act subsequent to  the
date of this Registration Statement and prior to the filing of  a
post-effective  amendment  which indicates  that  all  securities
offered  have  been  sold  or  which deregisters  all  securities
remaining  unsold shall be deemed to be incorporated by reference
into this Registration Statement and to be a part hereof from the
date  of filing of such documents.  Any statement contained in  a
document  incorporated or deemed to be incorporated by  reference
herein  shall be deemed to be modified or superseded for purposes
of  this  Registration Statement to the extent that  a  statement
contained  herein  or  in any other subsequently  filed  document
which also is or is deemed to be incorporated by reference herein
modifies or supersedes such statement.  The documents required to
be  so  modified or superseded shall not be deemed, except as  so
modified or superseded, to constitute a part of this Registration
Statement.

ITEM 4.   DESCRIPTION OF SECURITIES.  [Not required].

ITEM 5.   INTERESTS OF NAMED EXPERTS AND COUNSEL.

     Certain legal matters in connection with the issuance of the
Common  Stock  offered by this Registration Statement  are  being
passed  upon  for  the Company by Piper & Marbury  of  Baltimore,
Maryland.

ITEM 6.   INDEMNIFICATION OF DIRECTORS AND OFFICERS.

      Directors and officers of the Company are indemnified under
Section 2-418 of the Corporations and Associations Article of the
Annotated  Code of Maryland, and under Article EIGHTH, Section  7
of the Registrant's charter.

      As  permitted under Subsection (k) of Section 2-418 of  the
Corporations  and Associations Article of the Annotated  Code  of
Maryland,  the Company has purchased and maintains  insurance  on
behalf  of  its  directors  and officers  against  any  liability
asserted  against such directors and officers in their capacities
as  such  whether  or not the Company would  have  the  power  to
indemnify  such persons under the provisions of the Maryland  law
governing indemnification.

      As permitted by Maryland Law, Article Eighth, Section 8  of
the  Company's  Charter  limits the  monetary  liability  of  its
directors and officers to the Company and its stockholders to the
maximum  extent permitted by Maryland law in effect from time  to
time.  Section 8 of Article Eighth provides as follows:

          Section 8.  To the fullest extent permitted by Maryland
     statutory  or decisional law, as amended or interpreted,  no
     director  or officer of this Corporation shall be personally
     liable  to  the  Corporation or its stockholders  for  money
     damages.  No amendment of the charter of the Corporation  or
     repeal of any of its provisions shall limit or eliminate the
     benefits  provided  to  directors and  officers  under  this
     provision with respect to any act or omission which occurred
     prior to such amendment or repeal.

ITEM 7.   EXEMPTION FROM REGISTRATION CLAIMED.  Not
          applicable.

ITEM 8.   EXHIBITS.

Exhibit
Number    Description

 5        Opinion  of  Piper  &  Marbury  (contains  Consent   of
          Counsel).

 10.1     1995   Director  Stock  Option  Plan  of  the   Company
          (incorporated   by  reference  from  the   registrant's
          definitive  proxy statement for the annual  meeting  of
          stockholders held on April 6, 1995).

 10.2     Form of Non-Qualified Stock Option Agreement.

 23.1     Consent of Counsel (contained in Exhibit 5).

 23.2     Consent of Independent Accountants.

 24       Power of Attorney.

ITEM 9.   UNDERTAKINGS.

        The undersigned registrant hereby undertakes:

         (1)  To file, during any period in which offers or sales
are  being  made, a post-effective amendment to this registration
statement:

              (i)  To  include any prospectus required by section
10(a)(3) of Securities Act of 1933;

              (ii)  To  reflect in the prospectus  any  facts  or
events  arising  after  the effective date  of  the  registration
statement  (or the most recent post-effective amendment  thereof)
which,  individually or in the aggregate, represent a fundamental
change   in   the  information  set  forth  in  the  registration
statement;

              (iii)  To  include  any material  information  with
respect  to the plan of distribution not previously disclosed  in
the  registration  statement  or  any  material  change  to  such
information in the registration statement.

         (2)  That, for the purpose of determining any  liability
under  the  Securities  Act  of 1933,  each  such  post-effective
amendment  shall  be  deemed to be a new  registration  statement
relating  to the securities offered therein, and the offering  of
such  securities at that time shall be deemed to be  the  initial
bona fide offering thereof.

         (3)  To  remove from registration by means  of  a  post-
effective amendment any of the securities being registered  which
remain unsold at the termination of the offering.

         The  undersigned registrant hereby undertakes that,  for
purposes of determining any liability under the Securities Act of
1933,  each filing of the registrant's annual report pursuant  to
section 13(a) or section 15(d) of the Securities Exchange Act  of
1934  (and, where applicable, each filing of an employee  benefit
plan's  annual report pursuant to section 15(d) of the Securities
Exchange  Act of 1934) that is incorporated by reference  in  the
registration  statement shall be deemed to be a new  registration
statement  relating to the securities offered  therein,  and  the
offering  of such securities at that time shall be deemed  to  be
the initial bona fide offering thereof.

         Insofar as indemnification for liabilities arising under
the  Securities  Act  of  1933  may be  permitted  to  directors,
officers  and controlling persons of the registrant  pursuant  to
the  foregoing provisions, or otherwise, the registrant has  been
advised  that  in  the  opinion of the  Securities  and  Exchange
Commission  such  indemnification is  against  public  policy  as
expressed  in the Act and is, therefore, unenforceable.   In  the
event  that  a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or
paid  by  a  director,  officer  or  controlling  person  of  the
registrant  in  the  successful defense of any  action,  suit  or
proceeding)  is asserted by such director, officer or controlling
person  in  connection with the securities being registered,  the
registrant will, unless in the opinion of its counsel the  matter
has  been settled by controlling precedent, submit to a court  of
appropriate    jurisdiction    the    question    whether    such
indemnification  by it is against public policy as  expressed  in
the  Act  and will be governed by the final adjudication of  such
issue.


                           SIGNATURES

         Pursuant  to the requirements of the Securities  Act  of
1933, the registrant certifies that it has reasonable grounds  to
believe that it meets all of the requirements for filing on  Form
S-8  and has duly caused this registration statement to be signed
on  its behalf by the undersigned, thereunto duly authorized,  in
the City of Baltimore, and the State of Maryland on this 21st day
of April, 1995.

                              T. ROWE PRICE ASSOCIATES, INC.


                              By: /s/
                                  George J. Collins
                                  President, Chief Executive
                                  Officer and Managing Director


        Pursuant  to  the requirements of the Securities  Act  of
1933,  this registration statement has been signed below  by  the
following persons in the capacities and on the date indicated.


Principal Executive Officer:

/s/                       President, Chief        Date: April 21, 1995
George J. Collins         Executive Officer
                          and Managing
                          Director


Principal Financial Officer:

/s/                       Managing                Date: April 21, 1995
George A. Roche           Director and
                          Chief Financial Officer


Principal Accounting Officer:

/s/                        Managing Director       Date: April 21, 1995
Alvin M. Younger, Jr.      Treasurer and
                           Secretary



A Majority of the Board of Directors:

Thomas H. Broadus, Jr., George J. Collins, Carter O. Hoffman,
Henry H. Hopkins, James S. Riepe, George A. Roche, and M. David
Testa.


By:/s/                   For himself               Date: April 21, 1995
   George A. Roche       and as
                         Attorney-in-Fact



                         EXHIBIT INDEX

Exhibit
Number          Description      

 5              Opinion of Piper & Marbury (contains
                Consent of Counsel).

10.2            Form of Non-Qualified Stock Option Agreement.

23.1            Consent of Counsel (contained in Exhibit 5).

23.2            Consent of Independent Accountants.

24              Power of Attorney.


                                       PIPER & MARBURY                       
                                     CHARLES CENTER SOUTH                    
                                   36 SOUTH CHARLES STREET                   
                                Baltimore, Maryland 21201-3010               
                                         410-539-2530                        
                                      FAX: 410-539-0489    		 WASHINGTON
                                                           				 NEW YORK
                                                        			 PHILADELPHIA
                                                             				 LONDON
                                                          				EASTON, MD
                                                                             
                                                                             
                   
                   
                         April 21, 1995




T. Rowe Price Associates, Inc.
100 East Pratt Street
Baltimore, Maryland 21202

               Registration Statement on Form S-8

Dear Sirs:

      We  have  acted as counsel for T. Rowe Price Associates,
Inc.,  a  Maryland corporation (the "Company"), in  connection
with  a Registration Statement on Form S-8 which was filed  by
the Company under the Securities Act of 1933, as amended, (the
"Registration  Statement"), and which registers 70,000  shares
of the Common Stock of the Company (the "Shares") to be issued
pursuant to the Company's 1995 Director Stock Option Plan (the
"Director  Plan").   In that capacity, we  have  reviewed  the
charter   and   by-laws  of  the  Company,  the   Registration
Statement,  the  corporate action taken by  the  Company  that
provides  for  the issuance or delivery of the  Shares  to  be
issued  or  delivered under the Director Plan and  such  other
materials  and  matters as we have deemed  necessary  for  the
issuance of this opinion.

      Based upon the foregoing, we are of the opinion that the
Shares have been duly and validly authorized and upon issuance
and  delivery  thereof  as contemplated  in  the  Registration
Statement, will be, under the general corporation law  of  the
State  of  Maryland,  legally issued,  fully  paid,  and  non-
assessable.

           We  consent  to the filing of this  opinion  as  an
exhibit to the Registration Statement and to the reference  to
our  firm and to our opinion in the Registration Statement and
the prospectus which is a part thereof.

                                 Very truly yours,

                                 /s/ Piper & Marbury


 

                   	  STOCK OPTION AGREEMENT

                       	  pursuant to the

                	  T. ROWE PRICE ASSOCIATES, INC.

                	  1995 DIRECTOR STOCK OPTION PLAN

	                           


	       AGREEMENT, dated as of this 6th day of April, 1995, between T. ROWE
PRICE ASSOCIATES, INC. (the "Company"), and (the "Optionee").

	       WHEREAS, the Optionee is a Non-Employee Director of the Company (and
is not an employee of the Company or any of its affiliates or subsidiaries);
and

	       WHEREAS, the Company has and its stockholders have approved the
T. Rowe Price Associates, Inc. 1995 Director Stock Option Plan (the "Plan")
providing for the issuance of up to 70,000 shares of the Company's Common
Stock (par value $.20 per share)(the "Common Stock");

	       NOW THEREFORE, in consideration of the premises and of the mutual
covenants and agreements hereinafter set forth, the parties hereto hereby
mutually covenant and agree as follows:

	  	1.	Grant of Option.

	  	   Subject to the terms and conditions set forth herein, the Company
     hereby grants to the Optionee the option to purchase from the Company at
     a price of $38.375 per share, up to, but not exceeding in the aggregate
     4,000 shares of the Company's Common Stock.

	  	2.	Exercise of Option.

	     	(a)	The number of shares of Common Stock optioned hereby shall be
      exercisable in full commencing April 8, 1996.

	     	(b)	No less than 50 shares of Common Stock may be purchased upon any
      one exercise of the option granted hereby unless the number of shares
      purchased at such time is the total number of shares in respect of
      which the option granted hereby is then exercisable.

	     	(c)	In no event shall any option granted hereby be exercisable for a
      fractional share.

	     3.	Method of Exercising Option and Payment of Option Price.

	     	(a)	The option granted hereby shall be exercised by the Optionee
      delivering to the Secretary of the Company, from time to time, on any
      business day (the "Exercise Date"), written notice specifying the
      number of shares the Optionee then desires to purchase (the "Notice"),
      and either (i) cash, certified check, bank draft or postal or express
      money order to the order of the Company for an amount in United States
      dollars equal to the option price for the number of shares specified
      in the Notice (the "Total Option Price"), such payment to be delivered
      with the Notice, or (ii) shares of Common Stock of the Company with a
      value ((equal to or less than the Total Option Price, based on the
      market price of the Common Stock determined at the close of business
      on the Exercise Date on the Nasdaq National Market (or such other
      recognized securities market on which the Common Stock is traded if
      not then traded on the Nasdaq National Market)) plus cash, certified
      check, bank draft or postal or express money order to the order of
      the Company for an amount in United States dollars equal to the amount,
      if any, by which the Total Option Price exceeds the value of such shares 
	     of the Company's Common Stock.  Such Company's stock and cash shall be
      delivered to the Secretary of the Company not later than the end of the
      first business day after the Exercise Date.  In the case of payment in
      shares, such payment shall be made by delivery of the necessary share 
	     certificates, with executed stock powers attached, to the Secretary of
      the Company.  

	     	(b)	Within five business days after the Exercise Date, the Company
      shall, subject to the receipt of withholding tax, if any, issue to the
      Optionee the number of shares with respect to which such option shall
      be so exercised, and shall deliver to the Optionee a certificate or
      certificates therefor.

	  	4.	Termination.

	  	The option granted hereby shall terminate and be of no force or effect
   upon the first occurrence of any one of the following events:

  	  		(a)	The expiration of ten years from the date of this Agreement;

	     	(b)	Five years after the date the Optionee ceases to be a director of
      the Company for any reason, during which period any installments which
      first become exercisable may thereafter be exercisable.

	  	5.	Optionee.

	  	Whenever the word "Optionee" is used in any provision of this Agreement
   under circumstances where the provision should logically be construed to
   apply to the estate, personal representative, or beneficiary to whom this
   option may be transferred by will or by the laws of descent and
   distribution, it shall be deemed to include such person.

	  	6.	Assignability.

	  	This option is not transferable by the Optionee otherwise than by will or
   the laws of descent and distribution and is exercisable during the
   Optionee's lifetime only by the Optionee.  No assignment or transfer of
   this option, or of the rights represented thereby, whether voluntary or
   involuntary, by operation of law or otherwise, except by will or the laws
   of descent and distribution, shall vest in the assignee or transferee
   any interest or right herein whatsoever, but immediately upon any attempt
   to assign or transfer this option the same shall terminate and be of no
   force or effect.

	  	7.	Rights as a Stockholder.

	  	The Optionee shall not be deemed for any purpose to be a stockholder of
   the Company with respect to any shares as to which this option shall not
   have been exercised and payment and issue made as herein provided.
	
  	8.	The Company's Rights.

	  	The existence of this option shall not affect in any way the right or
   power of the Company or its stockholders to make or authorize any or all
   adjustments, recapitalizations, reorganizations or other changes in the
   Company's capital structure or its business or any merger or
   consolidation of the Company, or any issue of bonds, debentures,
   preferred or other stocks with preference ahead of or convertible into,
   or otherwise affecting the Common Stock or the rights thereof, or the
   dissolution or liquidation of the Company, or any sale or transfer of all
   or any part of its assets or business or any other corporate act or
   proceeding, whether of a similar character or otherwise.

	  	9.	Recapitalization.

	  	The shares with respect to which this option is granted are shares of the
   Common Stock of the Company as constituted on the date of this Agreement,
   but if, and whenever, prior to the delivery by the Company of all of the
   shares of Common Stock with respect to which this option is granted, the 
	  Company shall effect a subdivision or consolidation of shares, or other
   capital readjustment, or the payment of a stock dividend, or other
   increase or decrease in the number of shares of Common Stock outstanding,
   without receiving compensation therefor in money, services or property,
   then (a) in the event of any increase in the number of such shares
   outstanding, the number of shares of Common Stock then remaining subject
   to option hereunder shall be proportionately increased (except that any
   fraction of a share resulting from any such adjustment shall be excluded
   from the operation of this Agreement), and the cash consideration payable
   per share shall be proportionately reduced, and (b) in the event of a 
	  reduction in the number of such shares outstanding, the number of shares
   of Common Stock then remaining subject to option hereunder shall be
   proportionately reduced (except that any fractional share resulting from
   any such adjustment shall be excluded from the operation of this
   Agreement), and the cash consideration payable per share shall be
   proportionately increased.

	  	10.	Merger and Consolidation.

	  	After a merger of one or more corporations into the Company, or after a
   consolidation of the Company and one or more corporations in which the
   Company shall be the surviving or resulting corporation, the Optionee
   shall, at no additional cost, be entitled upon any exercise of this
   option, to receive (subject to any required action by stockholders) in
   lieu of the number of shares as to which this option shall then be so
   exercised, the number and class of shares of stock or other securities to
   which the Optionee would have been entitled pursuant to the terms of the
   agreement of merger or consolidation, if, immediately prior to such
   merger or consolidation, the Optionee had been the holder of record of a 
	  number of shares of Common Stock of the Company equal to the number of
   shares as to which such option shall be so exercised; provided, that
   anything herein contained to the contrary notwithstanding, 
	  upon the dissolution or liquidation of the Company, or upon any merger
   or consolidation, in which the Company is not the surviving or resulting
   corporation, this option shall terminate and be of no force or 
	  effect, except to the extent that such surviving or resulting corporation
   may issue a substituted option.

	  	11.	Preemption of Applicable Laws or Regulations.

	  	Anything in this Agreement to the contrary notwithstanding, if, at any
   time specified herein for the issue of shares to the Optionee, any law,
   regulation or requirements of any governmental authority having 
	  jurisdiction in the premises shall require either the Company or the
   Optionee to take any action in connection with the shares then to be
   issued, the issue of such shares shall be deferred until such action 
	  shall have been taken.

	  	12.	Notice.

	  	Any notice which either party hereto may be required or permitted to give
   to the other shall be in writing, and may be delivered personally or by
   mail, postage prepaid, addressed as follows: to the Secretary of the
   Company, or to the Company (attention of the Secretary), at 100 East Pratt
   Street, Baltimore, Maryland 21202, or at such other address as the
   Company, by notice to the Optionee, may designate in writing from time to
   time to the Optionee at the Optionee's address as shown on the records 
	  of the Company, or at such other address as the Optionee, by notice to the
   Secretary of the Company, may designate in writing from time to time.

	  	13.	Construction.

	  	This Agreement has been entered into in accordance with the terms of the
   Plan and wherever a conflict may arise between the terms of this
   Agreement and the terms of the Plan, the terms of the Plan shall control.

	  	14.	The option created by this Agreement shall not be treated as an
   incentive stock option.

	  	IN WITNESS WHEREOF, the Company has caused this Agreement to be executed
   by its duly authorized officer, and the Optionee has hereunto set his or
   her hand and seal all as of the day and year first above written.

	  				THE COMPANY:

	  				T. Rowe Price Associates, Inc.


	  				By:                                         


	  				THE OPTIONEE:


	  				                                           (L.S.)



                                 PIPER & MARBURY
                                 CHARLES CENTER SOUTH
                                 36 SOUTH CHARLES STREET
                         BALTIMORE, MARYLAND 21201-3010      WASHINGTON
                                 410-539-2530                 NEW YORK 
                                FAX: 410-539-0489           PHILADELPHIA
                                                            LONDON
                                                            EASTON, MD

                                     APRIL 21, 1995



T. Rowe Price Associates, Inc.
100 East Pratt Street
Baltimore, Maryland 21202

                      Registration Statement on Form S-8

Dear Sirs:

      We have acted as counsel for T. Rowe Price Associates, Inc., a Maryland
corporation (the "Company"), in connection with a Registration Statement on
Form S-8 which was filed by the Company under the Securities Act of 1933, as
amended, (the "Registration Statement"), and which registers 70,000 shares of
the Common Stock of the Company (the "Shares") to be issued pursuant to the
Company's 1995 Director Stock Option Plan (the "Director Plan").  In that
capacity, we have reviewed the charter and by-laws of the Company, the
Registration Statement, the corporate action taken by the Company that
provides for the issuance or delivery of the Shares to be issued or delivered
under the Director Plan and such other materials and matters as we have 
deemed necessary for the issuance of this opinion.

      Based upon the foregoing, we are of the opinion that the Shares have
been duly and validly authorized and upon issuance and delivery thereof as
contemplated in the Registration Statement, will be, under the gernal
corporation law of the State of Maryland, legally issued, fully paid, and
non-assessable.

      We consent to the filing of this opinion as an exhibit to the Regis-
tration Statement and to the reference to our firm and to our opinion in the
Registration Statement and the prospectus which is a part thereof.

                                     Very truly yours,
                                  
                                     /s/ Piper & Marbury





               CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in this
Registration Statement on Form S-8 of our report dated January
25, 1995, appearing on page 22 of the T. Rowe Price Associates,
Inc. Annual Report on Form 10-K for the year ended December 31,
1994.

/s/  PRICE WATERHOUSE LLP

Baltimore, Maryland
April 20, 1995

                                


                 T. ROWE PRICE ASSOCIATES, INC.
                                
                        Power of Attorney

     KNOW ALL MEN BY THESE PRESENTS, that the undersigned
directors and officers of T. Rowe Price Associates, Inc., a
Maryland corporation, constitute and appoint George J. Collins,
George A. Roche, and Alvin M. Younger, Jr. or any one of them,
the true and lawful agents and attorneys-in-fact of the
undersigned with full power and authority in said agents and
attorneys-in-fact, and in any one or more of them, to sign for
the undersigned in their respective names as directors and
officers of T. Rowe Price Associates, Inc., a Registration
Statement on Form S-8 (or other appropriate form) to be filed
with the Securities and Exchange Commission under the Securities
Act of 1933 and any amendment or supplement to such registration
statement relating to the sale of common stock under the T. Rowe
Price Associates, Inc. 1995 Director Stock Option Plan.  We
hereby confirm all acts taken by such agents and attorneys-in-
fact, or any one or more of them, as herein authorized.


DATED:    April 21, 1995




                                   /s/
                                   George J. Collins,
                                   Principal Executive Officer and Director


                                   /s/
                                   George A. Roche,
                                   Principal Financial Officer and Director


                                   /s/
                                   Alvin M. Younger, Jr.
                                   Principal Accounting Officer



	                                   /s/
            	 	                     Thomas H. Broadus, Jr.
                                
                                
                    	               /s/ 
                                    Carter O. Hoffman
                                
                                
                  	                 /s/
                        	           Henry H. Hopkins
                                
                                
                    	               /s/
                         	          James S. Riepe
                                
                                
                    	               /s/
                        	           M. David Testa



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission